PMA device
Raindrop® Near Vision Inlay
Rvo 2.0, Inc. (D.B.A. Optics Medical) · Implant, Corneal, Refractive (LQE, Class III) · First FDA decision Jun 29, 2016, newest Jan 4, 2022Keratoconus and corneal diseaseNearsightedness and refractive error
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
8
Naming "Raindrop Near Vision"
MAUDE reports
0
Brand "Raindrop Near Vision", since 2015
PubMed studies
12
Mentioning "Raindrop Near Vision"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Raindrop® Near Vision Inlay
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 5 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Raindrop Near Vision", any status and sponsor, newest update first.
Key-Whitman Eye CenterAcademic, hospital or other
NCT03101501 · 9 participants · Start Feb 14, 2017 · Primary completion Feb 1, 2018
Device: Raindrop Near Vision Inlay · For: Presbyopia
Sites: Bloomington, Minnesota; Dallas, Texas; San Antonio, Texas
Eye Center of North FloridaAcademic, hospital or other
NCT03326869 · 2 participants · Start Oct 18, 2017 · Primary completion Oct 23, 2018
Device: Raindrop Near Vision Inlay · For: Presbyopia
Sites: Panama City, Florida
ReVision Optics, Inc.Not on our public-company list
NCT01373580 · 373 participants · Start Apr 2010 · Primary completion Dec 2016
Device: The Raindrop Near Vision Inlay · For: Presbyopia
Sites: Camarillo, California; Laguna Hills, California; Newport Beach, California · 11 sites in all
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Raindrop Near Vision", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LQE
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Raindrop Near Vision"[tiab]. The summary above synthesizes these.
- Diagnostic and Management Tool for Monitoring Patients Implanted with a Shape-Changing Corneal Inlay.
Chu R, Lee BR · Case Rep Ophthalmol · 2018Case Reports
- Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval.
Hirani K, Bansinath M, Mittal R, et al. · J Ocul Pharmacol Ther · 2023Review
- Through-focus performance with a corneal shape-changing inlay: One-year results.
Whitman J, Hovanesian J, Steinert RF, et al. · J Cataract Refract Surg · 2016Clinical Trial, Research Support, Non-U.S. Gov't
- Treatment of Presbyopia in Emmetropes Using a Shape-Changing Corneal Inlay: One-Year Clinical Outcomes.
Whitman J, Dougherty PJ, Parkhurst GD, et al. · Ophthalmology · 2016Clinical Trial, Multicenter Study
- Surgical Correction of Presbyopic Ametropia With Non-refractive Transparent Corneal Inlay and an Implantable Collamer Lens.
Gutierrez Amoros C · J Refract Surg · 2016Case Reports
- Comparison of a hydrogel corneal inlay and monovision laser in situ keratomileusis in presbyopic patients: focus on visual performance and optical quality.
Verdoorn C · Clin Ophthalmol · 2017
- Hydrogel Inlay for Presbyopia: Objective and Subjective Visual Outcomes.
Yoo A, Kim JY, Kim MJ, et al. · J Refract Surg · 2015
- The Sensitivity of Clinical Outcomes to Centration on the Light-Constricted Pupil for a Shape-Changing Corneal Inlay.
Barragán-Garza E, Koch DD, Vargas LG, et al. · J Refract Surg · 2018
- Corneal remodeling after implantation of a shape-changing inlay concurrent with myopic or hyperopic laser in situ keratomileusis.
Steinert RF, Koch DD, Cochener B, et al. · J Cataract Refract Surg · 2017
- Range of refractive independence and mechanism of action of a corneal shape-changing hydrogel inlay: results and theory.
Steinert RF, Schwiegerling J, Lang A, et al. · J Cataract Refract Surg · 2015Multicenter Study
- Femtosecond laser-assisted cataract surgery after implantation of a transparent near vision corneal inlay.
Parkhurst GD, Garza EB, Medina AA · J Refract Surg · 2015Case Reports
- Safety and efficacy of a hydrogel inlay with laser in situ keratomileusis to improve vision in myopic presbyopic patients: one-year results.
Garza EB, Chayet A · J Cataract Refract Surg · 2015Clinical Trial, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LQE.
- Intacs Prescription Inserts/Intacs Corneal ImplantsAddition Technology · PMA 2024
- Kamra InlayCorneagen · PMA 2017
- ReVision Optics Raindrop Near Vision InlayRvo 2.0, Inc. (D.B.A. Optics Medical) · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.